Metropolis Healthcare Ltd (BOM:542650, NSE:METROPOLIS) said the completion of its acquisition of Dr. Ashok Kumar Sharma's Scientific Pathology is expected to be delayed by 15 days, according to a Saturday filing on the local bourse.
The company cited regulatory compliance under SEBI rules for the update.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。